First-in-human autologous implantation of genetically modified adipocytes expressing LCAT for the treatment of familial LCAT deficiency
Aso, M; Yamamoto, TT; Kuroda, M; Wada, J; Kubota, Y; Ishikawa, K; Maezawa, Y; Teramoto, N; Tawada, A; Asada, S; Aoyagi, Y; Kirinashizawa, M; Onitake, A; Matsuura, Y; Yasunaga, K; Konno, S; Nishino, K; Yamamoto, M; Miyoshi, J; Kobayashi, N; Tanio, M; Ikeuchi, T; Igari, H; Mitsukawa, N; Hanaoka, H; Yokote, K; Saito, Y
Yamamoto, TT (通讯作者)，CellGenTech Inc, Chiba 2600856, Japan.;Yokote, K (通讯作者)，Chiba Univ, Dept Endocrinol Hematol & Gerontol, Grad Sch Med, Chiba 2608670, Japan.;Yokote, K (通讯作者)，Chiba Univ Hosp, Dept Diabet Metab & Endocrinol, Chiba 2608670, Japan.
HELIYON, 2022; 8 (11):
